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Abstract 
 Blood circulation is the result of the beating of the heart, which provides the mechanical 
force to pump oxygenated blood to, and deoxygenated blood away from, the peripheral 
tissues. This depends critically on the preceding electrical activation. Disruptions in the 
orderly pattern of this propagating cardiac excitation wave can lead to arrhythmias. 
Understanding of the mechanisms underlying their generation and maintenance requires 
knowledge of the ionic contributions to the cardiac action potential, which is discussed in the 
first part of this review. A brief outline of the different classification systems for 
arrhythmogenesis is then provided, followed by a detailed discussion for each mechanism in 
turn, highlighting recent advances in this area. 
 
Introduction 
The heart beat provides the mechanical force for the pumping of oxygenated blood to, 
and deoxygenated blood away from, the peripheral tissues [1]. This depends critically on the 
orderly activation and recovery of electrical excitation through the myocardium. Disruptions 
of this can lead to arrhythmias. Understanding of the mechanisms underlying their generation 
and maintenance requires knowledge of the ionic contributions to the cellular action 
potential, which is discussed in the first part of this review. A brief outline of the different 
classification systems of arrhythmogenesis is then provided, followed by a discussion of each 
mechanism in turn, highlighting recent advances in this area. 
 
Cardiac action potential and its ionic contributions 
The cardiac action potential results from the sequential opening and closing of ion 
channel proteins that span the plasma membrane of individual myocytes. Its conduction 
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through the heart depends on electrical coupling between these cells, which is mediated by 
gap junctions [2]. Differences in the expression and properties of ion channels result in 
heterogeneities in action potential waveforms in different cardiac regions and cell types, and 
in the normal unidirectional spread of the action potentials through the heart [3]. The cardiac 
action potential in humans has five different phases (from 0 to 4). Depolarization from the SA 
node brings the membrane potential to the threshold, opening the voltage-activated sodium 
channels [4]. This allows the sodium ions to diffuse down their electrochemical gradient from 
the extracellular space, across the membrane and into the cell. The resulting sodium current, 
INa, produces a positive feedback loop that causes further sodium channels to open, and 
depolarization of the membrane proceeds until the sodium Nernst potential is reached or 
when the channels are inactivated. This is responsible for the rapid upstroke, termed phase 0, 
of the action potential.  
Early rapid repolarization then results from the activation of the fast and slow 
transient outward potassium currents, Ito,f and Ito,s, respectively, and is responsible for phase 1 
of the action potential. This is followed by a prolonged plateau resulting from a balance 
between the inward currents mediated by the voltage-gated L-type calcium channel (ICa,L) and 
sodium-calcium exchanger (INCX), and the outward currents mediated by the voltage-gated 
delayed rectifier potassium channels (IK) [5]. The rapid and slow currents (IKr and IKs, 
respectively) make up IK. There is also contribution from the inward rectifying current (IK1). 
This plateau is responsible for phase 2 of the action potential. The driving force for potassium 
efflux remains high during the plateau phase due to a large difference between the membrane 
potential and the potassium Nernst potential. As the calcium channels become inactivated, the 
outward potassium currents predominate, causing further repolarization and bringing the 
membrane potential towards the potassium equilibrium potential. This is responsible for 
phase 3 of the action potential. 
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The membrane potential returns to its resting value after full repolarization, which 
corresponds to phase 4 of the action potential, and is normally polarized at values between -
80 and -64 mV relative to the extracellular space [6]. This resting state is maintained mainly 
by the inward rectifier current, IK1. The weak inward rectifying ATP-dependent potassium 
channels (IK,ATP), activated by nucleotide diphosphates and inhibited by adenosine 
triphosphate, are also active during this phase. They are thought to provide a link between 
cellular metabolism and the membrane potential. 
Pacemaker cells are distinct from other cell types in showing automaticity, a property 
resulting from both voltage- and calcium-dependent mechanisms [7]. The former involves the 
funny current (If) carried by hyperpolarization-activated cyclic nucleotide-gated (HCN) 
channels [8], which have several unusual characteristics, such as activation on 
hyperpolarization, permeability to both sodium and potassium ions, modulation by 
intracellular cyclic AMP, and a small single channel conductance. The latter involves 
spontaneous calcium release from the sarcoplasmic reticulum [9], which activates INCX. Its 
crucial role was demonstrated in mice with complete atrial-specific knockout of NCX, which 
showed no pacemaker activity [10]. Both mechanisms result in spontaneous depolarization 
that is responsible for the rising slope of the membrane potential.  
 
Mechanisms of arrhythmias 
Several schemes have been used to classify the mechanisms of cardiac arrhythmias. 
Traditionally, these have been divided into nonreentrant and reentrant activity [11]. An 
alternative scheme divided them into those occurring at the cellular and tissue levels [12]. A 
dynamics-based classification, focusing on the trigger-tissue substrate interactions, divided 
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arrhythmogenic mechanisms into unstable calcium cycling, reduced repolarization reserve, 
and excess repolarization reserve [13].  
 
Focal activity 
Focal activity can arise from enhanced automaticity or triggered activity (Fig. 1).  
 
Enhanced automaticity 
Pacemaker cells are present in the SA node, atria, AV node, and the His-Purkinje 
system. In the human heart, the normal rate of discharge of the SA node is between 60 and 
100 beats per min (bpm). Subsidiary pacemakers discharge at slower rates. They are usually 
latent and reset by the dominant pacemaker with the highest intrinsic rate of discharge (i.e., 
the SA node). For example, the AV node discharges at 40 to 60 bpm and the Purkinje system 
discharges at 20 to 40 bpm. Enhanced automaticity of pacemaker cells can increase the rate 
of action potential discharge (Fig. 1). This can result from three main mechanisms: a negative 
shift in the threshold potential (TP, top broken arrow), a positive shift in the maximum 
diastolic potential (MDP, bottom broken arrow), and an increased rate of phase 4 
depolarization [14]. When this occurs in the SA node, it can lead to an increase in heart rate, 
termed sinus tachycardia. This can be physiological, due to increased sympathetic tone during 
exercise, or pathophysiological, due to hypovolemia, ischemia, or electrolyte disturbances. 
Moreover, tachycardia-bradycardia syndrome is alternating bradycardia and tachycardia, seen 
in patients with atrial fibrillation and sick sinus node syndrome [15]. Its underlying molecular 
mechanisms have not been fully elucidated. Recent evidence suggests a possible role of HCN 
channel downregulation in the SA node with a consequent decrease in If [16]. Furthermore, 
experiments in NCX knockout mice have demonstrated burst pacemaker activity, suggesting 
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a possible contributory role of NCX in tachycardia-bradycardia syndrome [17]. Both HCN 
and NCX are responsible for the “voltage clock” of pacemaker activity. It is possible that 
dysfunctions of the proteins involved in the “calcium clock” mechanism, for example, 
ryanodine receptor and sarcoplasmic reticulum Ca2+-ATPase, may also contribute [18].  
Enhanced automaticity can also occur in the AV node, under conditions of acute 
myocardial infarction, digitalis toxicity, isoprenaline administration, and recent cardiac 
surgery. When the discharge rate of the AV node is higher than the sinus rate, it can lead to 
abnormal rhythms called accelerated junctional rhythms [19]. These rhythms can occur at 
sites close to the atria, such as the pulmonary veins, superior vena cava, crista terminalis, 
coronary sinus, atrial septum, and the para-Hisian region that includes the tricuspid and mitral 
cannulae, leading to focal atrial tachycardia. 
Alternatively, parasystole occurs when a latent pacemaker is protected from the 
dominant pacemaker by entrance block and becomes ectopic, discharging action potentials 
independently (Fig. 2). A region of entrance block can occur when the dominant pacemaker 
is surrounded by ischemic, infarcted, or otherwise compromised tissues that prevent 
conduction of action potentials to the latent pacemaker. When this happens, action potentials 
generated by the latent pacemaker can exit and activate the rest of the myocardium. Thus, a 
parasystolic focus is formed when there are both compromised conduction into the ectopic 
pacemaker and exit conduction [20].  
Modulated parasystole is a variant of the above [21]. It results from incomplete 
entrance block of the ectopic pacemaker. In this situation, the dominant pacemaker or other 
cardiac tissues can exert electrotonic influences on the parasystolic focus. Electrotonic 
influences arriving early in the pacemaker cycle delay the firing of the parasystolic focus, 
whereas those arriving late in the cycle accelerate its firing. A special case of modulated 
parasystole occurs when the action potentials of the parasystolic focus exert electrotonic 
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influence on the focus itself. This is termed automodulation [22]. As has been shown in the 
atria, a parasystolic impulse exerts electrotonic influences on the parasystolic focus itself 
during the supernormal phase, where the focus accelerates rather than delays its discharge. 
Repetition of this mechanism would then result in a tachycardia [23]. 
 
Triggered activity 
Triggered activity results from the premature activation of cardiac tissues by 
afterdepolarizations, which are depolarizations triggered by one or more preceding action 
potentials [24, 25].  
 
Early afterdepolarizations 
Early afterdepolarizations (EADs) can develop before full repolarization, 
corresponding to phase 2 or phase 3 of the cardiac action potential in humans (Fig. 3). They 
are usually but not exclusively associated with prolonged action potential durations (APDs), 
which occur when the inward current is greater in amplitude than the outward current. 
Several factors can tip the balance towards the inward direction. These include increases in 
the late sodium current (INa), the calcium current (ICa), or INCX, or decreases in the 
repolarizing potassium currents (IKr, IKs, IK1). Two mechanisms have been proposed for the 
EADs that are associated with prolongations in APDs and occur during phase 2 of the action 
potential. Firstly, depolarizing shifts in the membrane potential can reactivate the L-type 
calcium channels [26], resulting in increased ICa,L that further depolarizes the membrane. This 
sets up a positive feedback loop, triggering an action potential. Secondly, at membrane 
potentials negative to the threshold of ICa,L activation (but before full repolarization), 
spontaneous calcium release from the sarcoplasmic reticulum can activate INCX [27], resulting 
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in membrane depolarization. The intermittent nature of EADs has recently been examined, 
demonstrating that it is due to slow changes in [Na+]i and potentially explaining why 
arrhythmias do not occur all the time [28]. 
EADs have also been associated with shortening in APDs, occurring late in phase 3 of 
the action potential [29]. Here, an abbreviated APD permits normal calcium release from the 
sarcoplasmic reticulum. If the intracellular calcium concentration ([Ca2+]i) remains elevated 
when the membrane potential is negative to the equilibrium potential for NCX, INCX can be 
activated, causing membrane depolarization. These late EADs are clinically relevant, as they 
can occur immediately after termination of other types of tachycardia, such as atrial flutter, 
AT, VT, and VF [30]. In such instances, repolarization time is shortened and a transient 
increase in sarcoplasmic calcium release can be induced when reverting to sinus rhythm. 
Whatever the underlying mechanism, if the change in membrane potential brought 
about by the EAD is sufficiently large, it will activate INa, resulting in triggered activity. 
EADs and their resulting triggered activity are thought to underlie the arrhythmogenesis 
observed in heart failure and long QT syndromes [31]. 
 
Delayed afterdepolarizations 
Delayed afterdepolarizations (DADs) were first described as oscillatory 
afterpotentials [32]. They can develop after full repolarization, corresponding to phase 4 of 
the cardiac action potential in humans (Fig. 3). DADs are observed under conditions of 
intracellular calcium overload, which can result from exposure to digitalis, catecholamines, 
hypokalemia, and hypercalcemia, and in hypertrophy and heart failure. The proposed 
mechanism for the genesis of DADs is as follows: high levels of intracellular calcium induce 
spontaneous calcium release from the sarcoplasmic reticulum, activating three calcium-
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sensitive currents—the nonselective cationic current, INS, the sodium-calcium exchange 
current, INCX, and the calcium-activated chloride current, ICl,Ca. Together, these constitute the 
transient inward current (ITI) that is responsible for membrane depolarization [33]. If the 
depolarization produced by the DAD is sufficiently large, INa is activated, leading to triggered 
activity. DAD-induced triggered activity is thought to underlie the arrhythmogenesis 
observed in catecholaminergic polymorphic ventricular tachycardia (CPVT) [34]. 
It is worth noting that DADs and late EADs are somewhat similar [30]. Both occur 
under conditions of intracellular calcium overload and involve spontaneous release of 
calcium from the sarcoplasmic reticulum. The difference appears to be the timing of this 
release [35], which occurs during the repolarizing phase of the action potential in the case of 
late EADs, and at the resting membrane potential for DADs. Indeed, for atrial fibrillation, 
both EADs and DADs have been implicated as the mechanisms of arrhythmogenesis [36]. 
.  
 
Reentry 
Re-entry occurs when an action potential fails to extinguish itself and reactivates a 
region that has recovered from refractoriness [37]. It can be divided into two types: i) reentry 
that occurs in the presence of an obstacle, around which an action potential can travel (circus-
type); and ii) reentry that occurs without an obstacle (reflection or phase 2).  
 
Circus-type reentry 
This occurs when an action potential travels around an anatomical or functional 
obstacle and reexcites its site of origin (Fig. 4).  
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Anatomical obstacle 
The ring model was the first example of circus-type reentry involving an anatomical 
obstacle. It emerged from experiments using disks made from sub-umbrella tissue of a 
jellyfish [38]. Mayer made the following observations. The disks were paralyzed when they 
were separated from their sense organs. They did not pulsate in seawater, but did so when 
ring-like cuts were made on the tissue. Upon mechanical stimulation, the disks then showed 
“rhythmical pulsations so regular and sustained as to recall the movement of clockwork” 
[38]. Later, Mines used a ring-like preparation of the tortoise heart, demonstrating that it was 
possible to initiate circus-type reentry by electrical stimulation [39]. If an excitation wave has 
a high propagation rate and a long duration, the whole circuit would be excited at the same 
time, causing the excitation to die out. In contrast, one with slower conduction and a shorter 
duration would permit the tissue ahead of the excitation wave to recover from refractoriness, 
which can therefore be reexcited, resulting in circus-type reentry. Mines predicted, “A 
circulating excitation of this type may be responsible for some cases of paroxysmal 
tachycardia as observed clinically.” He also proposed three criteria for this type of reentry: a) 
an area of unidirectional block must exist; b) the excitation wave propagates along a distinct 
pathway, returns to its point of origin, and starts again; and c) interruption of the circuit at 
any point would terminate this circus movement.  
It was recognized that conduction of the excitation must be sufficiently slow to allow 
the tissue ahead in the circuit to recover from refractoriness so that it can be reexcited. Thus, 
both the conduction velocity (CV) and the refractory period determine whether reentrant 
arrhythmogenesis occurs. It is useful to describe this excitation as a propagating wave, with a 
wave front that represents action potential depolarization, and a tail that represents 
repolarization [40]. The length of this excitation wave is given by the product of its CV and 
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refractory period [41], and must be smaller than the length of the circuit in order for reentry 
to be successful. Often, it is assumed that the end of the refractory period coincides with the 
end of the APD. 
 
Functional obstacle 
The possibility of circus-type reentry occurring without an anatomical obstacle was 
later suggested [42]. Direct evidence for this came from experiments demonstrating that 
premature electrical stimuli can induce tachycardia in isolated rabbit atrial preparations [43]. 
Electrical stimulation was applied at the center of the atrial tissue. Electrical activation 
initiated by regular stimuli spread normally throughout the tissue. In contrast, an impulse 
initiated by premature stimuli only propagates in the direction of shortened refractory periods 
and does so at a reduced CV. The unidirectional block of the premature impulse is caused by 
spatial dispersion in the refractory periods [44]. Furthermore, it was proposed that the center 
of the tissue was held above threshold by the electrotonic influences of the depolarization 
wave front, which revolved around this area, rendering it inexcitable. The excitation wave 
would then continue to revolve around this functional obstacle. Subsequent experiments then 
obtained transmembrane potential recordings, which led to the leading circle model [45]. 
Here, the circuit is defined entirely by the electrophysiological properties of the tissue. The 
smallest circuit permitting successful reentry, which was called the leading circle, is one in 
which the circulating wave front can just reexcite the tissue ahead that is still in the relative 
refractory period.  
The CV of the propagating action potential depends on the wave curvature. For a 
planar wave, each cell activates one cell downstream. For a wave front curving inwards 
(concave), each cell will be activating less than one cell downstream. This source-sink 
12 
 
mismatch will increase the depolarizing current available for each downstream cell, resulting 
in a greater rate of voltage rise, and therefore, a higher CV compared to that of a planar wave. 
The opposite is true for a wave front curving outwards (convex), where each cell will be 
activating more than one cell downstream, and thus the CV will be smaller than that of a 
planar wave. If the curvature is sufficiently convex, conduction block can result [46]. The 
point where the activation and repolarization wave fronts meet is called the phase singularity 
[47]. This corresponds to a nonexcited point because all phases of the wave meet here.  
A variation of functional reentry termed spiral wave reentry was later described. A 
spiral wave is a two-dimensional wave of excitation emitted by a self-organizing source of 
functional reentrant activity, termed a rotor. The three-dimensional equivalent of a spiral 
wave is a scroll wave. Spiral waves were described earlier in the Belousov–Zhabotinsky 
chemical reaction, in which cerium ions catalyze the oxidation of malonic acid by bromate. In 
this reaction, the ratio of cerium (IV) to cerium (III) undergoes repeated temporal 
oscillations, generating spiral waves with alternating colors. Spiral waves have been 
subsequently reproduced in models of cardiac tissue and demonstrated in thin slices of 
epicardial muscle using a potentiometric dye, which changes its spectral properties in 
response to voltage changes. Experiments have shown that the phase singularity is excitable 
but remains nonexcited, and therefore acts as a functional obstacle around which the spiral 
wave can circulate [48].  
Spiral waves are not fixed in space but can drift through the tissue [49]. This drift 
phenomenon is accompanied by a Doppler effect, in which the frequency of excitation at a 
given measurement site depends on the location of this site relative to the drifting spiral wave 
[50]. Thus, the sites in front of the wave are excited faster than those behind the wave. This 
may be the underlying mechanism of torsade de pointes [51], in which the periodic torsion of 
the QRS axis has been attributed to two widely separated foci discharging at different 
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frequencies. Two counter-rotating spiral waves separated by a small distance can produce 
reentry in a figure-of-eight configuration, which was first demonstrated in the canine heart 
using a healed myocardial infarction model [52].  
 
Reentry not involving an obstacle 
Reentry can also occur without circus movement. This can be divided into reflection 
and phase 2 reentry. 
 
Reflection 
The possibility of reflection was first suggested by a report that investigated the role 
of slowed action potential conduction in reentrant excitation using excised canine Purkinje 
fibers [53]. Depressed excitability in discrete segments of the fibers was produced by 
increasing the extracellular potassium concentrations. The authors made the following 
observations. An action potential traveling in the forward direction was sometimes followed 
by a return extrasystole that traveled in the backward direction through the original route. 
This only occurred when the initiating impulse reached an area of depressed excitability. It 
was noted that the return extrasystole could arise from circus movement within the depressed 
segment, a mechanism proposed earlier [54].  
Later, reflection was demonstrated as a mechanism of reentrant arrhythmogenesis 
using the sucrose gap model [55]. Experiments used ion-free isotonic sucrose solution to 
create a central inexcitable gap in canine Purkinje fibers, thereby dividing them into three 
segments (Fig. 5). Electrical stimulation at the proximal segment elicits an action potential. 
This excitation is transmitted across the gap to the distal segment after a delay. However, this 
cannot be active in the form of action potentials because the extracellular space is ion-free, 
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but instead involves passive spread of the local current (electrotonic current) across the low-
resistance intracellular pathway. When depolarization reaches threshold, an action potential is 
initiated in the distal segment. This in turn generates electrotonic currents in the retrograde 
direction. With a further delay, the proximal region can be reexcited when it has recovered 
from refractoriness, resulting in a return extrasystole, completing reflection [55]. Successful 
segment-type reflection requires a balance between the conduction delay and the cellular 
membrane excitability [56]. A slightly different model of reflection involved immersion of 
the Purkinje fibers in a solution containing high concentrations of potassium and lactic acid to 
mimic the extracellular milieu that is present during ischemia [57]. This also renders the 
central segment inexcitable. Segment-type reflection has been demonstrated in isolated atrial 
[58] and ventricular [59] tissues.  
Recently, a different type of reflection, called the expansion-type, has been 
demonstrated [60]. Antegrade propagation of an impulse occurs from a narrow isthmus 
region to an expanded distal region. The activation wave front has an outward curvature 
(convex) and stimulates a higher number of cells in the expanded region, where the source-
sink mismatch is greatest. This causes the direction of electrotonic currents to be reversed, in 
turn prolonging the action potential. This in turn initiates retrograde propagation along the 
same path.  
 
Phase 2 reentry 
Phase 2 reentry is another mechanism that does not depend on circus-type movement 
[61]. Its concept emerged from experiments that introduced pinacidil, an activator of the 
ATP-regulated potassium current, IK,ATP, to canine ventricular tissues. The canine ventricular 
action potentials have a “spike and dome” morphology. Pinacidil increases IK,ATP, resulting in 
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the shortening of APDs and thus loss of the action potential dome. However, this effect is 
much more prominent in the epicardium than in the endocardium, possibly because of a 
smaller endocardial Ito, and any changes produced there by pinacidil would be less dramatic. 
Propagation of the action potential dome from sites where it is maintained to sites where it is 
abolished can then result in an extrasystole [62]. Electrotonic currents can flow from sites 
with longer APDs to sites with shorter APDs, and can cause reexcitation when the latter sites 
have recovered from refractoriness [63]. The arrhythmogenesis in Brugada syndrome is 
thought to involve phase 2 reentry, where the resulting premature beat initiates spontaneous 
polymorphic VT. Heterogeneity in action potential repolarization between cardiac regions 
leading to phase 2 reentry occurs following exposure to the sodium channel inhibitor 
flecainide and under conditions of raised [Ca2+]i and ischemia [64]. Phase 2 reentry, e.g., 
from ischemia, can also initiate circus-type reentry [65].  
The concept of prolonged repolarization-dependent reexcitation (PRDR) proposed 
earlier [66] is also similar to that of phase 2 reentry. PRDR requires an area of myocardium 
with prolonged repolarization connected to another area with a normal repolarization time-
course. For example, EADs can prolong repolarization and the resulting triggered activity in 
Purkinje fibers can conduct to the connecting ventricular muscle [67]. However, in PRDR, 
prolonged APDs per se do not cause reexcitation of the regions with shorter APDs, as they do 
in phase 2 reentry. Rather, secondary depolarizations such as EADs or their resulting 
triggered activity in the affected region provide an additional current source. Together, the 
local circuit currents generated by the APD difference and by the EAD provide the necessary 
depolarizing currents for an extrasystole in the affected region. Furthermore, in PRDR, the 
interaction is between sites with prolonged and normal APDs, whereas in phase 2 reentry, it 
is between sites with normal and shortened APDs [64]. Nevertheless, both mechanisms 
require an increased transmural heterogeneity in the time courses of repolarization. 
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Trigger versus substrate? 
Traditional views have considered trigger and substrate as independent entities [68]. 
Examples of triggers are EADs and DADs, which can induce ectopic beats. Substrate refers 
to electrophysiological abnormalities predisposing to reentry, including increased dispersion 
of conduction or repolarization, and abnormal restitution [69]. However, evidence suggests 
that the trigger itself can produce the necessary substrate for reentry, e.g., DADs inducing 
unidirectional block [70]. Conversely, reentry may be the triggering event for an arrhythmia. 
Thus, phase 2 reentry can produce closely coupled ectopic beats capable of initiating circus-
type reentry in Brugada syndrome [71].  
 
Future directions 
Novel antiarrhythmic agents that have been developed are mainly for the management 
of atrial fibrillation, targeting atrial-specific ion channels [72]. An example is vernakalant, a 
multichannel blocker of the ultra-rapid (IKur) and acetylcholine-activated (IK, ACh) potassium 
currents. This has minimal effects on the ventricles [73], and is thus less likely to induce 
malignant ventricular arrhythmias. However, there has been no recently licensed drug for the 
treatment of ventricular arrhythmias, although ranolazine, a late INa inhibitor licensed for 
angina, has demonstrated efficacy in experimental studies [74]. There is a need to develop 
new drugs for several reasons. First, implantable cardioverter-defibrillators (ICDs) are not 
able to prevent the occurrence of ventricular arrhythmias, but can only terminate them, and 
are not without significant morbidity. Yet, they are the only form of treatment shown to 
increase life expectancy. Secondly, current pharmacological agents possess significant 
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cardiac and extracardiac side effects, the most concerning of which are their proarrhythmic 
properties [75].  
A potential solution is the rational design of agents that target the abnormal proteins 
concerned. Thus, EADs observed in long QT syndrome type 3 could be prevented by drugs 
inhibiting the late INa [76]. DADs underlying CPVT may be abolished by blocking the 
ryanodine receptors, which mediate calcium release from the sarcoplasmic reticulum [77], or 
the sodium-calcium exchanger [78]. Cardiac-specific KATP channels, which are activated by 
ATP depletion during ischemia, are currently under investigation [79]. Furthermore, 
understanding the physiology of arrhythmogenesis, for example, the substrates that sustain 
reentry, can guide drug development. Thus, heterogeneities in action potential conduction or 
repolarization, observed in a number of ion channelopathies, may be reduced by gap junction 
openers [80].   
In summary, this article reviewed the physiological mechanisms of non-reentrant and 
reentrant arrhythmias. Their generation and maintenance are important in both congenital and 
acquired arrhythmic syndromes. In the future, antiarrhythmic drugs have the potential to 
match device-based therapy and catheter ablation in terms of efficacy. Research efforts on 
their development therefore warrant further exploration. 
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Figures 
Figure 1. Enhanced pacemaker can occur via three mechanisms: a negative shift in the 
threshold potential (TP), a positive shift in the maximum diastolic potential (MDP), and an 
increased rate of phase 4 depolarization. 
Figure 2. Protected pacemaker. Entrance block of the dominant pacemaker allows exit 
conduction of the subsidiary pacemaker, which can generate action potentials that excite the 
rest of the myocardium. 
Figure 3. Afterdepolarization phenomena: early afterdepolarization (EAD) occurs early 
(phase 2) or late (phase 3), and delayed afterdepolarization (DAD) occurs during phase 4 of 
the action potential. 
Figure 4. Circus-type reentry requires a structural or functional obstacle (grey center) around 
which an action potential can circulate. 
Figure 5. Reflection. Stimulation of the proximal segment elicits an action potential. Its 
conduction across the middle segment can not take place actively as the extracellular region 
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is ion-free. Instead, it involves electrotonic current spread intracellularly. After a delay, when 
the membrane potential reaches threshold at the distal segment, another action potential is 
generated. 
 
